Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Phase II/III Trial of Sentinel Lymph Node Biopsy Versus Elective Neck Dissection for Early-Stage Oral Cavity Cancer

NCT04333537 is registered in ClinicalTrials.gov with NRG Oncology as lead sponsor.

NCT NCT04333537
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04333537 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Phase II/III Trial of Sentinel Lymph Node Biopsy Versus Elective Neck Dissection for Early-Stage Oral Cavity Cancer
Lead sponsor
NRG Oncology
Phase
Phase 2/3
Overall status
Recruiting
Start date
September 23, 2020
Completion date
April 27, 2036
Enrollment
686 (estimated)
Sites
107

Conditions

As the registry lists them; a condition with its own page is linked.

buccal mucosa squamous cell carcinoma, floor of mouth squamous cell carcinoma, gingival squamous cell carcinoma, hard palate squamous cell carcinoma, lip squamous cell carcinoma, lower alveolar ridge squamous cell carcinoma, oral cavity squamous cell carcinoma, retromolar trigone squamous cell carcinoma, stage i lip and oral cavity cancer ajcc v8, stage ii lip and oral cavity cancer ajcc v8, tongue squamous cell carcinoma, upper alveolar ridge squamous cell carcinoma